Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 6/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.35 |
| ▸ | TP53 | P04637 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | ACAT1 | P24752 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
| ▸ | LYPLA1 | O75608 | 1/20 | 0.35 |
| ▸ | LYPLA2 | O95372 | 1/20 | 0.35 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2268513 | 0.88 | GAA (0.40) | ALOX5CYP3A4PTPN1PPARDGAA | |
| SCHEMBL4160114 | 0.87 | TSHR (0.38) | SIRT1ALOX5PTGS2TP53TSHR | |
| SCHEMBL3796380 | 0.76 | GRM2 (0.36) | SIRT1LMNAGAAMEN1KMT2A | |
| SCHEMBL2797809 | 0.68 | SIRT1 (0.44) | SIRT1TP53MAPTCYP3A4PTPN1 | |
| SCHEMBL19359096 | 0.67 | PTPN1 (0.49) | SIRT1PTGS2TP53KDM4EMAPT | |
| SCHEMBL20929943 | 0.64 | CNR2 (0.61) | CNR1CNR2 | |
| SCHEMBL5430441 | 0.63 | CNR2 (0.63) | CNR1CNR2 | |
| SCHEMBL10575460 | 0.62 | PPARD (0.54) | SIRT1TP53MAPTCYP3A4PTPN1 | |
| Syringic Acid SCHEMBL31550974 | 0.60 | CA12 (0.79) | ALOX5PTGS2TSHRLMNAHTT | |
| Syringic Acid SCHEMBL31550982 | 0.60 | CA12 (0.79) | ALOX5PTGS2TSHRLMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 930 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3965739-B1 | TABLET DOSAGE FORMULATIONS OF OLEYL PHOSPHOCHOLINE | OBLITA THERAPEUTICS BVBA (BE) | 2024-07-10 | — | — | EP | claimed |
| US-12011496-B2 | Topical macqui berry formulation | Tracie Martyn International, Inc. (US) | 2024-06-18 | — | — | US | claimed |
| US-20240173228-A1 | COSMETIC COMPOSITION COMPRISING HINOKITIOL | CONOPCO, INC., D/B/A UNILEVER (US) | 2024-05-30 | — | — | US | claimed |
| US-11992544-B2 | Topical composition | DSM IP ASSETS B.V. (NL) | 2024-05-28 | — | — | US | claimed |
| CN-112739423-B | Mineral sunscreen compositions with improved efficacy | 莱雅公司 | 2024-04-30 | — | — | CN | claimed |
| CN-113893818-B | Surface-modified zeolite, agilawood essential oil for slimming, extraction method and application | 广州东智盟化妆品有限公司 | 2024-04-26 | — | — | CN | claimed |
| WO-2024073219-A1 | STABLE SKIN CARE COMPOSITIONS CONTAINING A RETINOID | THE PROCTER & GAMBLE COMPANY (US) | 2024-04-04 | — | — | WO | claimed |
| US-20240099944-A1 | Stable Skin Care Compositions Containing a Retinoid | THE PROCTER & GAMBLE COMPANY | 2024-03-28 | — | — | US | claimed |
| US-11911347-B2 | Compositions comprising one or more (bio)-alkanediols with antioxidants | SYMRISE AG (DE) | 2024-02-27 | — | — | US | claimed |
| EP-4319884-A1 | COSMETIC COMPOSITION COMPRISING HINOKITIOL | Unilever IP Holdings B.V. (NL) | 2024-02-14 | — | — | EP | claimed |
| US-20070185038-A1 | Regulation of mammalian keratinous tissue using skin care actives | THE PROCTER & GAMBLE COMPANY | 2007-08-09 | — | — | US | claimed |
| WO-2007041548-A2 | COMPOSITION FOR REGULATION OF MAMMALIAN KERATINOUS TISSUE | THE PROCTER & GAMBLE COMPANY (US) | 2007-04-12 | — | — | WO | claimed |
| US-20070065396-A1 | Topical macqui berry formulation | TRACIE MARTYN INTERNATIONAL, LLC | 2007-03-22 | — | — | US | claimed |
| US-20070020221-A1 | Regulation of mammalian keratinous tissue using personal care compositions comprising cetyl pyridinium chloride | PROCTER & GAMBLE COMPANY, THE | 2007-01-25 | — | — | US | claimed |
| WO-2007001904-A2 | PERSONAL CARE COMPOSITIONS COMPRISING ALPHA-GLUCANS AND/OR BETA-GLUCANS | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-04 | — | — | WO | claimed |
| US-20060263321-A1 | Regulation of mammalian keratinous tissue using personal care compositions comprising diethylhexyl syringylidene malonate | THE PROCTER & GAMBLE COMPANY | 2006-11-23 | — | — | US | claimed |
| WO-2006124990-A2 | REGULATION OF MAMMALIAN KERATINOUS TISSUE USING PERSONAL CARE COMPOSITIONS COMPRISING CETYL PYRIDINIUM CHLORIDE | THE PROCTER & GAMBLE COMPANY (US) | 2006-11-23 | — | — | WO | claimed |
| WO-2006124989-A1 | REGULATION OF MAMMALIAN KERATINOUS TISSUE USING PERSONAL CARE COMPOSITIONS COMPRISING TETRAHYDROCURCUMIN | THE PROCTER & GAMBLE COMPANY (US) | 2006-11-23 | — | — | WO | claimed |
| WO-2006124991-A1 | REGULATION OF MAMMALIAN KERATINOUS TISSUE USING PERSONAL CARE COMPOSITIONS COMPRISING DIETHYLHEXYL SYRINGYLIDENE MALONATE | THE PROCTER & GAMBLE COMPANY (US) | 2006-11-23 | — | — | WO | claimed |
| US-20060263309-A1 | Regulation of mammalian keratinous tissue using personal care compositions comprising tetrahydrocurcumin | PROCTER & GAMBLE COMPANY, THE | 2006-11-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070020221-A1 | Regulation of mammalian keratinous tissue using personal care compositions comprising cetyl pyridinium chloride | RBP1, PROC, RBP4 | SIRT1 996/4885ALOX5 3542/4885PTGS2 3906/4885 |
| US-20060263309-A1 | Regulation of mammalian keratinous tissue using personal care compositions comprising tetrahydrocurcumin | KRT18, DSC1, PPHLN1 | SIRT1 1506/4885ALOX5 4611/4885PTGS2 2266/4885 |
| US-11911347-B2 | Compositions comprising one or more (bio)-alkanediols with antioxidants | MMP8, CXCL8, IL18 | SIRT1 1080/4885ALOX5 153/4885PTGS2 200/4885 |
| US-20060263321-A1 | Regulation of mammalian keratinous tissue using personal care compositions comprising diethylhexyl syringylidene malonate | KRT18, DSG1, MAL2 | SIRT1 2547/4885ALOX5 4437/4885PTGS2 4366/4885 |
| US-20070185038-A1 | Regulation of mammalian keratinous tissue using skin care actives | CUTA, KDM7A, KDM2A | SIRT1 2676/4885ALOX5 2339/4885PTGS2 3487/4885 |
| US-20240173228-A1 | COSMETIC COMPOSITION COMPRISING HINOKITIOL | MITF, SUV39H2, SUV39H1 | SIRT1 930/4885ALOX5 1946/4885PTGS2 2341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.